arrow
S

Shuan Rao

Nanfang Hospital
H指数:31
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis

靶向DDX3X通过破坏抗氧化稳态并诱导铁死亡,抑制了KRAS驱动的肺癌进展。

2025-08-300
OAAI
Author Correction: SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming

作者更正:SHP-1抑制靶向白血病干细胞,通过代谢重编程恢复免疫监视并增强化疗敏感性

2025-08-110
OAAI
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
2022-08-3120
OA
EMERGE: A phase II trial assessing the efficacy of domatinostat plus avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal cancers - phase IIA dose finding
2021-09-015
OAAI
HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases
2020-07-1522
OAAI